Published in J Virol on April 01, 1997
How will HPV vaccines affect cervical cancer? Nat Rev Cancer (2006) 2.23
Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. J Virol (1998) 1.85
Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro. J Virol (1998) 1.67
Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J Virol (2001) 1.55
Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol (1999) 1.52
Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies. J Virol (1998) 1.49
In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res (1998) 1.44
The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J Clin Microbiol (1998) 1.25
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. J Virol (2003) 1.12
L2, the minor capsid protein of papillomavirus. Virology (2013) 1.07
Chaperone-mediated in vitro disassembly of polyoma- and papillomaviruses. J Virol (2006) 1.02
Perspectives for preventive and therapeutic HPV vaccines. J Formos Med Assoc (2010) 0.99
Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers. J Virol (2005) 0.98
Possible role for cellular karyopherins in regulating polyomavirus and papillomavirus capsid assembly. J Virol (2008) 0.97
Emerging human papillomavirus vaccines. Expert Opin Emerg Drugs (2012) 0.96
Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells. Appl Environ Microbiol (2006) 0.93
Structure-based engineering of papillomavirus major capsid l1: controlling particle assembly. Virol J (2007) 0.92
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer. Biologics (2008) 0.92
Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity. J Virol (2009) 0.89
A parameter estimation technique for stochastic self-assembly systems and its application to human papillomavirus self-assembly. Phys Biol (2010) 0.88
Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres. Virol J (2009) 0.88
Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1. Virol J (2008) 0.84
Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation. PLoS One (2013) 0.84
Capsomer vaccines protect mice from vaginal challenge with human papillomavirus. PLoS One (2011) 0.83
The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation. J Gen Virol (2015) 0.81
Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum. BMC Biotechnol (2007) 0.81
Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chem Soc Rev (2016) 0.77
Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus. Virus Res (2016) 0.76
Current status of human papillomavirus vaccines. J Formos Med Assoc (2010) 0.75
Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens. Infect Agent Cancer (2008) 0.75
Effects of siRNA-mediated suppression of HPV-11 L1 expression on the proliferation and apoptosis of vaginal epithelial cells. Exp Ther Med (2017) 0.75
Characterization of human papillomavirus type 16 pseudovirus containing histones. BMC Biotechnol (2016) 0.75
Papillomavirus assembly: An overview and perspectives. Virus Res (2016) 0.75
Expression of human papillomavirus 6b L1 protein in silkworm larvae and enhanced green fluorescent protein displaying on its virus-like particles. Springerplus (2012) 0.75
Human papillomavirus major capsid protein L1 remains associated with the incoming viral genome throughout the entry process. J Virol (2017) 0.75
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A (1992) 7.72
Structure of simian virus 40 at 3.8-A resolution. Nature (1991) 5.96
Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J (1991) 4.07
Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol (1993) 4.00
Self-assembly of purified polyomavirus capsid protein VP1. Cell (1986) 4.00
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 3.65
Structural polypeptides of rabbit, bovine, and human papillomaviruses. J Virol (1975) 2.83
Polymorphism in the assembly of polyomavirus capsid protein VP1. Biophys J (1989) 2.74
Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure (1996) 2.49
Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J Gen Virol (1993) 2.42
Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. J Virol (1987) 2.01
Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology (1994) 1.89
Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. J Virol (1994) 1.83
Site-directed mutation affecting polyomavirus capsid self-assembly in vitro. Nature (1987) 1.75
Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1. J Virol (1991) 1.70
Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles. J Gen Virol (1994) 1.60
Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J Gen Virol (1994) 1.57
DNA-binding activity of papillomavirus proteins. J Virol (1987) 1.54
Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1. J Virol (1991) 1.49
Conserved features in papillomavirus and polyomavirus capsids. J Mol Biol (1996) 1.47
Polyoma virus major capsid protein, VP1. Purification after high level expression in Escherichia coli. J Biol Chem (1985) 1.46
Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor. J Virol (1995) 1.32
Characterization of a nuclear localization sequence in the polyomavirus capsid protein VP1. Virology (1991) 1.23
Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein. Virology (1991) 1.21
Antibody-mediated neutralization of human papillomavirus type 11 (HPV-11) infection in the nude mouse: detection of HPV-11 mRNAs. J Infect Dis (1992) 1.20
Metal-free southern bean mosaic virus crystals. J Biol Chem (1979) 1.09
In vitro assay for protein-protein interaction: carboxyl-terminal 40 residues of simian virus 40 structural protein VP3 contain a determinant for interaction with VP1. Proc Natl Acad Sci U S A (1988) 1.07
Stabilizing effect of divalent metal ions on virions of southern bean mosaic virus. Virology (1976) 1.05
Divalent ion-dependent reversible swelling of tomato bushy stunt virus and organization of the expanded virion. J Mol Biol (1982) 1.00
Expression of the polyomavirus minor capsid proteins VP2 and VP3 in Escherichia coli: in vitro interactions with recombinant VP1 capsomeres. J Virol (1995) 0.95
Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol (1993) 4.00
Self-assembly of purified polyomavirus capsid protein VP1. Cell (1986) 4.00
Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene. EMBO J (1987) 3.65
Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell (2000) 3.44
Amino acid sequences that determine the nuclear localization of yeast histone 2B. Mol Cell Biol (1987) 3.31
Evidence that a human beta-tubulin pseudogene is derived from its corresponding mRNA. Nature (1982) 3.08
Polymorphism in the assembly of polyomavirus capsid protein VP1. Biophys J (1989) 2.74
Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc Natl Acad Sci U S A (1986) 2.62
Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. J Biol Chem (1984) 2.58
Studies on the electrical potential profile across rabbit ileum. Effects of sugars and amino acids on transmural and transmucosal electrical potential differences. J Gen Physiol (1971) 2.42
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med (1992) 2.28
Substrate specificity of the dsRNA unwinding/modifying activity. EMBO J (1991) 2.18
Role of DNA and specific cytoplasmic receptors in glucocorticoid action. Proc Natl Acad Sci U S A (1972) 1.97
Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. J Virol (1998) 1.85
Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain. EMBO J (1988) 1.79
A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior. J Virol (1991) 1.77
Site-directed mutation affecting polyomavirus capsid self-assembly in vitro. Nature (1987) 1.75
Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1. J Virol (1991) 1.70
Host range transforming gene of polyoma virus plays a role in virus assembly. Proc Natl Acad Sci U S A (1983) 1.69
Muscle development in Caenorhabditis elegans: mutants exhibiting retarded sarcomere construction. Cell (1978) 1.61
Myosins exist as homodimers of heavy chains: demonstration with specific antibody purified by nematode mutant myosin affinity chromatography. Cell (1978) 1.60
Regulation of c-myc and c-fos mRNA levels by polyomavirus: distinct roles for the capsid protein VP1 and the viral early proteins. Proc Natl Acad Sci U S A (1987) 1.58
Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J Virol (2001) 1.55
In vivo and in vitro association of hsc70 with polyomavirus capsid proteins. J Virol (1995) 1.52
Virion assembly defect of polyomavirus hr-t mutants: underphosphorylation of major capsid protein VP1 before viral DNA encapsidation. J Virol (1985) 1.50
Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papillomavirus type 11 origin. J Virol (1993) 1.50
Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1. J Virol (1991) 1.49
Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies. J Virol (1998) 1.49
Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J Mol Biol (2001) 1.46
Polyoma virus major capsid protein, VP1. Purification after high level expression in Escherichia coli. J Biol Chem (1985) 1.46
The spineless-aristapedia and tango bHLH-PAS proteins interact to control antennal and tarsal development in Drosophila. Development (1999) 1.43
Immunological analyses of human papillomavirus capsids. Vaccine (2001) 1.40
Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology (1995) 1.37
Electrical properties of isolated human gallbladder. Am J Physiol (1973) 1.37
SV40-like sequences in human bone tumors. Oncogene (1996) 1.33
Expression of the polyomavirus VP2 and VP3 proteins in insect cells: coexpression with the major capsid protein VP1 alters VP2/VP3 subcellular localization. Virology (1993) 1.32
Simian virus 40-induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome. Am J Pathol (1992) 1.24
Characterization of a nuclear localization sequence in the polyomavirus capsid protein VP1. Virology (1991) 1.23
A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers. J Infect Dis (2001) 1.20
In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J Virol (1998) 1.20
Antibody-mediated neutralization of human papillomavirus type 11 (HPV-11) infection in the nude mouse: detection of HPV-11 mRNAs. J Infect Dis (1992) 1.20
Nuclear import of HPV11 L1 capsid protein is mediated by karyopherin alpha2beta1 heterodimers. J Cell Biochem (1999) 1.16
Efficient transformation by Prague A Rous sarcoma virus plasmid DNA requires the presence of cis-acting regions within the gag gene. J Virol (1987) 1.16
Coordinate synthesis of two myosins in wild-type and mutant nematode muscle during larval development. Cell (1978) 1.13
Isolation and characterization of polyoma nucleoprotein complexes. Virology (1983) 1.12
Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Mol Endocrinol (1992) 1.11
Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis. Oncogene (2009) 1.10
Propagation of human papillomavirus type 11 in human xenografts using the severe combined immunodeficiency (SCID) mouse and comparison to the nude mouse model. Virology (1993) 1.09
Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata. J Gen Virol (1991) 1.09
Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region. J Gen Virol (1989) 1.07
Direct observation of defect structure in protein crystals by atomic force and transmission electron microscopy. Biophys J (1992) 1.03
T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J Virol (1998) 1.03
Solubility properties of reduced and oxidized ascorbate as determinants of membrane permeation. Biochim Biophys Acta (1987) 1.03
Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA. J Virol (2001) 1.02
Human progesterone receptor binding to mouse mammary tumor virus deoxyribonucleic acid: dependence on hormone and nonreceptor nuclear factor(s). Mol Endocrinol (1989) 1.00
Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology (2001) 1.00
The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions. J Infect Dis (2000) 1.00
Nuclear import and DNA binding of human papillomavirus type 45 L1 capsid protein. J Cell Biochem (2000) 0.99
Comparative studies of histone acetylation in nucleosomes, nuclei, and intact cells. Evidence for special factors which modify acetylase action. J Biol Chem (1980) 0.99
Interpretation of X chromosome dose at Sex-lethal requires non-E-box sites for the basic helix-loop-helix proteins SISB and daughterless. Mol Cell Biol (2001) 0.98
Dehydroascorbic acid and ascorbic acid transport systems in the guinea pig ileum. Am J Physiol (1986) 0.98
Identification of the threonine phosphorylation sites on the polyomavirus major capsid protein VP1: relationship to the activity of middle T antigen. J Virol (1994) 0.97
Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP). Virology (1992) 0.97
Transcription and in vitro processing of yeast 5 S rRNA. J Biol Chem (1980) 0.97
Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system. Mol Endocrinol (1991) 0.96
Effect of histamine on technetium-99m excretion by gastric mucosa. Surgery (1976) 0.96
Abnormalities in gallbladder morphology and function in patients with cholelithiasis. Ann Surg (1976) 0.95
Expression of the polyomavirus minor capsid proteins VP2 and VP3 in Escherichia coli: in vitro interactions with recombinant VP1 capsomeres. J Virol (1995) 0.95
Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells. Proc Natl Acad Sci U S A (1997) 0.95
Water soluble antioxidants in mammalian aqueous humor: interaction with UV B and hydrogen peroxide. Vision Res (1998) 0.93
Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse. J Virol (1998) 0.93
Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia. J Med Virol (2000) 0.93
Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene (2001) 0.93
Choline influx across the brush border of guinea pig jejunum. Biochim Biophys Acta (1977) 0.93
Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Arch Virol (2003) 0.92
Human growth hormone gene and the highly homologous growth hormone variant gene display different splicing patterns. J Clin Invest (1988) 0.92
Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia. J Med Virol (2001) 0.92
"Local rules" theory applied to polyomavirus polymorphic capsid assemblies. Virology (2000) 0.91
Intracellular Cl concentrations and influxes across the brush border of rabbit ileum. Am J Physiol (1973) 0.90
Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol (1991) 0.90
Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication. Cancer Gene Ther (2008) 0.89
Interaction of glucocorticoid receptor-steroid complexes with acceptor sites. J Biol Chem (1976) 0.89
Ascorbic acid flux across mucosal border of guinea pig and human ileum. Am J Physiol (1977) 0.89
Difference between the abilities of human Fcgamma receptor-expressing CV-1 cells to neutralize American and Asian genotypes of dengue virus 2. Clin Vaccine Immunol (2008) 0.88
Detergent action of sodium taurocholate on rat gastric mucosa. Biochim Biophys Acta (1972) 0.88
VEGF blockade decreases the tumor uptake of systemic oncolytic herpes virus but enhances therapeutic efficacy when given after virotherapy. Gene Ther (2010) 0.87
Intestinal ascorbic acid transport following diets of high or low ascorbic acid content. Int J Vitam Nutr Res (1978) 0.87
Erythema and conjunctivitis. Outbreak caused by inadvertent exposure to ultraviolet light. JAMA (1979) 0.86
Ascorbic acid regeneration by bovine iris-ciliary body. Curr Eye Res (1993) 0.86
Polyomavirus VP1 phosphorylation: coexpression with the VP2 capsid protein modulates VP1 phosphorylation in Sf9 insect cells. Proc Natl Acad Sci U S A (1995) 0.86
Seroresponses to virus-like particles of human papillomavirus types 16, 18, 31, 33, and 45 in San people of Southern Africa. J Med Virol (2000) 0.85
Water-soluble vitamin absorption in intestine. Annu Rev Physiol (1980) 0.85